Medirom director discloses 1,200 common shares

Medirom Healthcare Technologies Inc. director Nojima Akira has reported initial beneficial ownership of 1,200 Common Shares.

Accepted by SEC EDGAR 03/18/2026 - 01:24 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medirom Healthcare Technologies Inc. director Nojima Akira has reported initial beneficial ownership of 1,200 Common Shares. These shares are held directly, and the filing does not reflect any recent buy or sell activity, only the director’s current equity position in the company.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Nojima Akira

Role Director

Type	Security	Shares	Price	Value
Holding	Common Shares	--	--	--

Holdings: Common Shares — 1,200 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Nojima Akira’s Form 3 filing for MRM show?

The Form 3 shows that director Nojima Akira beneficially owns 1,200 Common Shares of Medirom Healthcare Technologies Inc. This filing records an existing ownership position rather than reporting a new purchase or sale of shares.

Did Nojima Akira buy or sell Medirom (MRM) shares in this Form 3?

No new transaction is indicated. The Form 3 for Medirom (MRM) simply lists 1,200 Common Shares held by director Nojima Akira after the reported date, without showing any specific buy or sell action.

How many Medirom (MRM) shares does director Nojima Akira hold?

Director Nojima Akira is reported as holding 1,200 Common Shares of Medirom Healthcare Technologies Inc. The shares are shown as directly owned, providing a snapshot of the director’s equity position at the time of the filing.

Is the Form 3 for Medirom (MRM) a routine insider ownership filing?

Yes. The Medirom (MRM) Form 3 is a routine insider ownership filing that records 1,200 Common Shares held by director Nojima Akira. It establishes baseline ownership rather than signaling a new trading decision.

Does Medirom’s Form 3 filing indicate any derivative securities for Nojima Akira?

The filing only shows Common Shares and reports 1,200 shares held after the reporting date. No derivative securities, such as options or warrants, are listed for director Nojima Akira in this Form 3 summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nojima Akira

(Last) (First) (Middle)

2-3-1 DAIBA

(Street)

MINATO-KU 135-0091

(City) (State) (Zip)

JAPAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Medirom Healthcare Technologies Inc. [ MRM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	1,200	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Akira Nojima Name: Akira Nojima	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)